banner
Stigmasterol glucoside/polyethylene glycol derivative-modified cationic liposomes
Inquiry

Cat. No.: X26-05-ZQ1472

Stigmasterol glucoside/polyethylene glycol derivative-modified cationic liposomes

Synonym: Stigmasterol glucoside/PEG derivative cationic liposomes; Stigmasterol glucoside-PEG modified cationic LPs; Stigmasterol glucoside PEGylated cationic liposomes

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This highly complex system features stigmasterol glucoside and polyethylene glycol derivative co-modified cationic liposomes. The structural matrix incorporates synthetic cationic lipids alongside a high proportion of polyethylene glycol (PEG) derivative-modified lipids and the plant-derived sterol conjugate stigmasterol glucoside. This complex configuration introduces a dense hydrophilic steric shield paired with a strongly positive surface charge topography and a distinct glycosylated sterol structural network. The structural integrity of the composite shell prevents vesicle aggregation and controls the passive release behavior of internal spaces during automated transport modeling.
Source
Custom synthesis
Functional Group
Stigmasterol glucoside; Polyethylene glycol derivative; Cationic lipid
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.